8PX-11714-31179
4 vaccinations
3 coded responses
31 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 606 / IL
- Registered
- 2021-04-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-17
Registered in v-safe
-
2021-04-17
Dose 1 — Moderna
- 2021-04-17
-
2021-04-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-16
-
2021-05-18
Dose 2 — Moderna
-
2021-05-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-05-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · HeadacheAdult check-in
- 2021-05-21
- 2021-05-22
- 2021-05-23
- 2021-05-24
- 2021-05-27
- 2021-06-01
- 2021-06-08
- 2021-06-15
- 2021-06-22
- 2021-06-29
-
2021-11-16
Survey response — 6 months, dose 2MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy · Healthcare visit (other): PhysicalMedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-11-17
-
2021-12-15
Dose 3 — Pfizer-BioNTech
- 2022-05-18
-
2022-09-15
Dose 4 — ModernaCo-administered: Flu
- 2022-10-04
- 2022-10-06
-
2022-10-13
Survey response — day 28, dose 4MedDRA: Nasopharyngitis, Oropharyngeal pain, Productive cough — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold / phlegm / sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-10-22
- 2022-10-27
- 2022-12-15
-
2023-03-16
Survey response — 6 months, dose 4MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-17 | Moderna | |
| 2 | 2021-05-18 | Moderna | |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
| 4 | 2022-09-15 | Moderna | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — 6 months, dose 2
Release 12 — day 28, dose 4
Symptoms: Cold / phlegm / sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release